KEMRON - LOW-DOSE NATURAL HUMAN INTERFERON-ALPHA FOR ORAL-ADMINISTRATION - (GENERAL INFORMATION AND TECHNICAL DETAILS)

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:SS82 / SS86
页数:5
相关论文
共 50 条
  • [41] 3 YEARS CONTINUOUS LOW-DOSE INTERFERON-ALPHA TREATMENT OF HAIRY-CELL LEUKEMIA - EVALUATION OF RESPONSE AND MAINTENANCE DOSE
    NIELSEN, B
    BRAIDE, I
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1992, 49 (04) : 174 - 179
  • [42] INTERFERON-ALPHA PLUS LOW-DOSE CYTOSINE-ARABINOSIDE IN ADVANCED PHASE CHRONIC MYELOGENOUS LEUKEMIA PATIENTS
    FERRAJOLI, A
    LIBERATI, AM
    CARICCHI, P
    DONTI, E
    MORRA, E
    LAZZARINO, M
    BETTI, AR
    BERNASCONI, P
    SAGLIO, G
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1995, 55 (03) : 184 - 188
  • [43] SUCCESSFUL TREATMENT OF A PATIENT WITH ADULT T-CELL LEUKEMIA BY DAILY ORAL-ADMINISTRATION OF LOW-DOSE ETOPOSIDE
    KOJIMA, H
    HORI, M
    SHIBUYA, A
    NAGASAWA, T
    MIWA, M
    ABE, T
    CANCER, 1993, 72 (12) : 3614 - 3617
  • [44] Phase II clinical trial of low-dose interleukin-2, interferon-alpha, and low-dose tegafur uracil therapy for advanced renal cell cancer.
    Kato, Tomoyuki
    Iwamura, Masatsugu
    Fujita, Tetsuo
    Saito, Seiichi
    Ohshiro, Yoshinori
    Imai, Tomoyuki
    Kawata, Nozomu
    Tomita, Yoshihiko
    Sejima, Takehiro
    Kishida, Takeshi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [45] RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND-STUDY OF LOW-DOSE ORAL INTERFERON-ALPHA IN HIV-1 ANTIBODY POSITIVE PATIENTS
    HULTON, MR
    LEVIN, DL
    FREEDMAN, LS
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1992, 5 (11): : 1084 - 1090
  • [46] Low-dose natural human interferon-α lozenges in the treatment of Behcet's syndrome
    Kilic, Hasan
    Zeytin, Hasan E.
    Korkmaz, Cengiz
    Mat, Cem
    Gul, Ahmet
    Cosan, Fulya
    Dinc, Ayhan
    Simsek, Ismail
    Sut, Necdet
    Yazici, Hasan
    RHEUMATOLOGY, 2009, 48 (11) : 1388 - 1391
  • [47] Low-dose oral administration of interferon-α for the treatment of immune-mediated keratoconjunctivitis sicca in dogs
    Gilger, BC
    Rose, PD
    Davidson, MG
    Roberts, SM
    Miller, T
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (08): : 901 - 905
  • [48] Low-dose intravenous bolus interleukin-2 with interferon-alpha therapy for metastatic melanoma and renal cell carcinoma
    Karp, SE
    JOURNAL OF IMMUNOTHERAPY, 1998, 21 (01): : 56 - 61
  • [49] Intermittent, low-dose interferon-alpha therapy reduces the relapse rate in anti-HBE positive chronic hepatitis
    Krastev, ZA
    Antonov, KA
    Vassilev, M
    Jelev, DT
    JOURNAL OF HEPATOLOGY, 2003, 38 : 147 - 147
  • [50] TREATMENT OF ADVANCED STAGES OF PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA AND LOW-DOSE CYTARABINE
    KANTARJIAN, HM
    KEATING, MJ
    ESTEY, EH
    OBRIEN, S
    PIERCE, S
    BERAN, M
    KOLLER, C
    FELDMAN, E
    TALPAZ, M
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (05) : 772 - 778